Joshua Lederberg
Corporate Officer/Principal bij The Rockefeller University
Profiel
Dr. Lederberg is currently University Professor-Emeritus at The Rockefeller University, having previously served as its President.
His awards and recognitions include the National Academy of Sciences, Royal Society of London, US Medal of Science, and many more.
He has published extensively on infectious disease and biowarfare defense, and serves on the Defense Science Board and the DTRA Advisory Council.
Dr. Lederberg received his PhD from Yale University in microbiology.
Dr. Lederberg was awarded the Nobel Prize in Medicine for studies on the organization of the genetic material in bacteria.
Actieve functies van Joshua Lederberg
| Bedrijven | Functie | Begin |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
Eerdere bekende functies van Joshua Lederberg
| Bedrijven | Functie | Einde |
|---|---|---|
| The Rockefeller University | President | - |
Paladin Capital Group
 Paladin Capital Group Investment ManagersFinance Paladin Capital Group (Paladin Capital) is a private equity subsidiary of Penn Ave Investments LLC founded by Mark Maloney and Michael Steed in 2001. The firm is headquartered in Washington, DC with offices in New York City, Silicon Valley, London and Luxembourg. | Private Equity Investor | - |
Opleiding van Joshua Lederberg
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Paladin Capital Group
Paladin Capital Group Investment ManagersFinance Paladin Capital Group (Paladin Capital) is a private equity subsidiary of Penn Ave Investments LLC founded by Mark Maloney and Michael Steed in 2001. The firm is headquartered in Washington, DC with offices in New York City, Silicon Valley, London and Luxembourg. | Finance |
